These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: a quasi-experimental case-crossover study. Palese A; Aidone E; Dante A; Pea F J Cardiovasc Nurs; 2013; 28(5):473-82. PubMed ID: 22760174 [TBL] [Abstract][Full Text] [Related]
16. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin. Koch P; Münssinger T; Rupp-John C; Uhl K J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306 [TBL] [Abstract][Full Text] [Related]
18. Generalised cutaneous necrosis: a complication of low-molecular-weight heparin. Patel GK; Knight AG Int Wound J; 2005 Sep; 2(3):267-70. PubMed ID: 16618332 [TBL] [Abstract][Full Text] [Related]
19. Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT). Bratt G; Aberg W; Johansson M; Törnebohm E; Granqvist S; Lockner D Thromb Haemost; 1990 Dec; 64(4):506-10. PubMed ID: 1964751 [TBL] [Abstract][Full Text] [Related]
20. Delayed hypersensitivity at the injection sites of a low-molecular-weight heparin. Moreau A; Dompmartin A; Esnault P; Michel M; Leroy D Contact Dermatitis; 1996 Jan; 34(1):31-4. PubMed ID: 8789222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]